Glucagon‐Like Peptide‐1 Receptor Agonist‐Based Agents and Body Composition: Filling More Gaps
Authors' conclusion
Similar to our previous report, we found that the changes in body composition using these agents remain in the upper range of expected % FFML using other nonsurgical interventions for obesity.
Study context
- Population
- Reports assessing changes in body composition by DXA with GLP-1 RA-based agents for obesity40 DXA-based reports
- Outcome
- Weight lost as % fat-free mass (% FFML)
Methodological detailsupdate of previous review, DXA-based reports
- Update of previous review
- DXA-based reports
Main finding
As reported in the abstract
% fat-free mass loss (% FFML)
Mean (SD) % FFML across 40 DXA-based reports
29.1%
19.0%
Original publication
Glucagon‐Like Peptide‐1 Receptor Agonist‐Based Agents and Body Composition: Filling More Gaps. Obesity (Silver Spring). Published 8 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →